Business
BioSpectrum Asia
Singapore demonstrates quantum recoil, paving way for precise X-ray imaging in healthcare
For the first time since it was proposed over 80 years ago, scientists from Nanyang Technological University, Singapore (NTU Singapore) have demonstrated the phenomenon of \"quantum recoil\", which describes how the particle nature of light has a major impact on electrons moving through materials.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Australia turns back the clock on damaged heart tissue
An international team of researchers, led by University of Sydney in Australia, has developed a method to reverse the loss of elasticity of damaged heart tissue following heart attacks.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Former FDA medical device officer joins Pulnovo Medical's scientific advisory board
China-based Pulnovo Medical has announced the appointment of Dr Mingdong Zhang to the company’s Scientific Advisory Board (SAB).
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
SK Bioscience accelerates global growth strategy by picking talent from Big Pharma
South Korea-based SK bioscience has announced that Richard Kensinger, PhD, former Director and Head of Drug Substance Process Development in SanofiPasteur and former Executive Director of Process Development and Protein Sciences at Affinivax Inc. has joined in ‘SK bioscience USA Inc.’ as Vice President of R&D Project Management. Dr Kensinger is an expert who has been dedicated to biopharmaceutical R&D, working at global companies for more than 20 years.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Dr David John Jeans steps in as HistoIndex's Non-Executive Chairman
Rockwell Automation, dedicated to industrial automation and digital transformation across sectors including pharma and healthcare, has appointed Mariya Prempeh as country manager for Singapore, effective immediately.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Rockwell appoints Mariya Prempeh Singapore Country Manager
Rockwell Automation, dedicated to industrial automation and digital transformation across sectors including pharma and healthcare, has appointed Mariya Prempeh as country manager for Singapore, effective immediately.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Asieris Pharma appoints Dr Linda Wu as Chief Development Officer
Asieris Pharmaceuticals, a China-based biopharma company specialising in discovering, developing and commercialising innovative drugs for the treatment of genitourinary tumours and other related diseases, has announced that Linda Wu, PhD will join Asieris as Chief Development Officer.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Chaitanya Sarawate steps in as India MD for Wipro GE Health Care
Wipro GE HealthCare has announced the appointment of Chaitanya Sarawate as the Managing Director (MD), Wipro GE HealthCare and President & CEO, GE HealthCare South Asia.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Goa Institute of Management launches professional certificate programme in healthcare
Goa Institute of Management (GIM) in India has launched a Professional Certificate Programme in Healthcare Management powered by Asia’s largest higher Edtech Company, upGrad.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Singapore unveils talent development strategy to boost Healthtech and Biotech ecosystem
Considering Singapore’s RIE2025 initiative, SGInnovate’s Helix Immersion Programme will support Singapore’s growing biomedical and biotech companies.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
VALUE is the Trending Word of 2023
The last two years saw a significant leap toward patient-centricity in the pharmaceutical space. although this next iteration will focus on leveraging the industry's growing digital maturity to offer increased patient value while achieving measurable business goals.
5 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
"Australia is poised to establish itself as a global life sciences hub"
Synthetic biology markets are experiencing a surge in demand for molecular diagnostics and technological advances in molecular biology, spurring growth in the Assay and Reagent market in Asia Pacific.
4 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
"We're dedicated to Multiple Sclerosis with two approved therapies and Evobrutinib currently in phase 3 trial"
Rare diseases remain untreatable globally despite major advances in research that have enabled us to understand their molecular basis, as well as legislation that provides regulatory and economic incentives to encourage their development.
5 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
"Global investors can leverage our deep immunomics platform to develop TCR Cell therapies for solid tumours"
The global biotech ecosystem continues to fluctuate and pose fresh challenges but many emerging enterprises and technologies are keen to collaborate with other stakeholders to solve healthcare challenges.
5 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
"We need to foster risky projects that can have large rewards"
Synthetic lethality is a promising area of cancer therapy. Anticancer Bioscience (ACB) is a precision oncology company, applying synthetic lethal approaches to develop targeted cancer therapies.
4 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
"Technology will play a significant role in reducing numbers of new cases and deaths"
‘Close the care gaps’ – a bold theme set for 2022-2024 World Cancer Day campaigns that fall on February 4 each year – intends to make a huge difference in delivering cancer care to the people.
5 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
CANCER THERAPEUTICS GAINING GROUND IN APAC
Cancer, the leading cause of death in most parts of the world, is a veritable Achilles heel for the pharma industry.
10+ min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Addressing Unmet Patient Needs in Antimicrobial Resistance (AMR): The Vital Role of Industry Partnerships
Interview- Mr Maurizio Luongo and Mr Zhao Hong
6 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Veradigm announces strategic investment in Holmusk from Singapore
US-based Veradigm has announced an investment in Holmusk, a global behavioural health real-world evidence and data analytics company in Singapore, as part of Holmusk’s $45 million series B financing round.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
DeepTek introduces new Al powered lumbar spine quantification automation tool
India-based health tech startup DeepTek has announced the global launch of DeepSpine - an artificial intelligence (AI) powered lumbar spine quantification and metrics tool designed to analyse MRI lumbar spine images.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Moderna buys Japanese startup OriCiro for $85M
OriCiro Genomics, founded in December 2018, is focussed on the development and commercialisation of cellfree synthesis
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
China's ReLive Biotechnologies strengthens presence in regenerative therapy market
Simultaneously with the acquisition, ReLive also completed its Series A financing of $36 million to fund the company’s global ambition.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Seno Medical enters exclusive distributor agreement with Genetik
Seno Medical, based in the US, has entered into an exclusive distributor agreement with Genetik, to market, sell and service the company’s groundbreaking Imagio Opto-Acoustic/ Ultrasound (OA/US) Breast Imaging System.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Malaysian Genomics explores R&D collaboration with SIRIM
Under the strategic cooperation, both parties will evaluate the potential commercial value of a range of genomicsdriven biotechnology R&D projects.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Terumo and Siemens Healthineers collaborate to strengthen cardiac care in India
The collaboration will flag off its efforts with a customised training programme for Cathlab professionals, being developed in partnership with an eminent academic institute in India.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Aculys Pharma, Four H initiate collaboration using wearable devices to study sleep disorders in Japan
In its quest to establish a new pharmaceutical model, Aculys is promoting DX (digital transformation) in clinical trials and medicine.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Lotte Biologics announces $3 B investment plan to leap forward as global CDMO
Lotte Biologics CEO Richard Wonjik Lee has announced a blueprint to leap forward as a global contract development and manufacturing organisation (CDMO).
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Sun Pharma buys US-based Concert Pharma for $576 M
Sun Pharma’s immediate focus would be to follow Concert’s plan to submit a New Drug Application (NDA) to the US Food and Drug Administration (FDA) in the first half of 2023.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
SK bioscience's shingles vaccine receives biologics license application approval in Malaysia
SKYZoster is shown clinically acceptable immunogenicity and safety at Phase III clinical trial.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Mobile app to help adolescents access public health services in Bangladesh
Millions of adolescents and youth in Bangladesh will be able to access health information and services through two online portals launched recently at The National Adolescent Health Conference held in Dhaka.
1 min |